{"disease":{"id":"ultra-high-power-ablation-safety-of-atrial-fibrillation-ablation","name":"ultra high power ablation safety of atrial fibrillation ablation"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06699368","title":"Clinical Study on the Risk of Left Atrial POP Ablation and Esophageal Injury Under Ultra-High Power and Related Influencing Parameters","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":120,"lead_sponsor_name":"The Third People's Hospital of Chengdu","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}